Moreover, it is known that the upregulation of Akt and NF-κB signaling pathways is related to the activation of cyclin D1 that leads to proliferation of cancer cells [21,71] and decline in CDKI, p21, thus inhibiting apoptosis [72,73,74,75,76,77]. This evidence concerns the gene NFKB1 and cancer.